Waverley Pharma Inc. (WAVE.V)
TSXV · CAD · Healthcare · Biotechnology
CA$0.01 (+0.00%) as of
Key statistics
- Market cap
- 540.00k
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.0100 – 0.0400
- Beta
- 1.46
- Revenue (TTM)
- 1.17M
- Profit margin
- -63.40%
- Volume
- 2.00k
About Waverley Pharma Inc.
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. In addition, it is involved in the sale of prescription medications, over-the-counter products, and associated pharmacy services. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Winnipeg, MB, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.